↑Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle H (1990). "Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals". Neurology. 40 (11): 1770–6. PMID1700336.
↑Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R (2000). "Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand". Nat. Med. 6 (10): 1167–75. doi:10.1038/80516. PMID11017150.
↑Sriram S, Mitchell W, Stratton C (1998). "Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS". Neurology. 50 (2): 571–2. PMID9484408.
↑Soldan SS, Jacobson S (2001). "Role of viruses in etiology and pathogenesis of multiple sclerosis". Adv. Virus Res. 56: 517–55. PMID11450311.
↑Friese MA, Schattling B, Fugger L (2014). "Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis". Nat Rev Neurol. 10 (4): 225–38. doi:10.1038/nrneurol.2014.37. PMID24638138.
↑Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005). "Cortical demyelination and diffuse white matter injury in multiple sclerosis". Brain. 128 (Pt 11): 2705–12. doi:10.1093/brain/awh641. PMID16230320.